Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metals | 3 | 2021 | 137 | 1.910 |
Why?
|
| Prostheses and Implants | 4 | 2021 | 151 | 1.780 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2021 | 14 | 1.420 |
Why?
|
| Osteolysis | 2 | 2021 | 137 | 1.170 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2016 | 34 | 1.060 |
Why?
|
| Caspase 1 | 3 | 2021 | 14 | 0.950 |
Why?
|
| Inflammasomes | 3 | 2021 | 16 | 0.940 |
Why?
|
| Wounds, Penetrating | 1 | 2020 | 7 | 0.700 |
Why?
|
| Immunoglobulins | 1 | 2020 | 21 | 0.700 |
Why?
|
| Military Personnel | 1 | 2020 | 27 | 0.690 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 73 | 0.680 |
Why?
|
| Foreign Bodies | 1 | 2020 | 28 | 0.680 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2019 | 10 | 0.640 |
Why?
|
| Th17 Cells | 1 | 2019 | 22 | 0.640 |
Why?
|
| Alloys | 2 | 2016 | 89 | 0.630 |
Why?
|
| Inflammation | 2 | 2019 | 255 | 0.610 |
Why?
|
| Signal Transduction | 2 | 2019 | 380 | 0.610 |
Why?
|
| Joint Prosthesis | 1 | 2019 | 74 | 0.600 |
Why?
|
| Metals, Heavy | 1 | 2016 | 6 | 0.540 |
Why?
|
| Cobalt | 2 | 2016 | 107 | 0.540 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2016 | 25 | 0.540 |
Why?
|
| Prosthesis Failure | 3 | 2019 | 484 | 0.500 |
Why?
|
| Osteoporosis | 1 | 2016 | 74 | 0.500 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 9 | 0.440 |
Why?
|
| Macrophages | 4 | 2021 | 104 | 0.440 |
Why?
|
| Particulate Matter | 1 | 2013 | 16 | 0.440 |
Why?
|
| Vitallium | 1 | 2013 | 25 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 359 | 0.390 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2016 | 174 | 0.380 |
Why?
|
| Mice | 3 | 2021 | 1198 | 0.370 |
Why?
|
| Animals | 4 | 2021 | 3382 | 0.360 |
Why?
|
| Breast Implants | 2 | 2021 | 5 | 0.350 |
Why?
|
| Interleukin-17 | 2 | 2021 | 13 | 0.350 |
Why?
|
| Interleukin-1beta | 4 | 2016 | 46 | 0.330 |
Why?
|
| Monocytes | 4 | 2016 | 58 | 0.320 |
Why?
|
| Cell Line | 2 | 2016 | 240 | 0.240 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 2 | 2021 | 5 | 0.230 |
Why?
|
| Immunity, Innate | 2 | 2021 | 54 | 0.220 |
Why?
|
| Male | 5 | 2021 | 13573 | 0.220 |
Why?
|
| Humans | 9 | 2021 | 25227 | 0.210 |
Why?
|
| Cells, Cultured | 3 | 2019 | 468 | 0.200 |
Why?
|
| Breast Implantation | 1 | 2021 | 3 | 0.190 |
Why?
|
| Skull | 1 | 2021 | 21 | 0.190 |
Why?
|
| Interferon-gamma | 1 | 2021 | 59 | 0.190 |
Why?
|
| In Vitro Techniques | 2 | 2019 | 169 | 0.190 |
Why?
|
| Hypersensitivity | 1 | 2021 | 39 | 0.180 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 77 | 0.180 |
Why?
|
| Bone Resorption | 1 | 2021 | 74 | 0.180 |
Why?
|
| Cytokines | 2 | 2019 | 201 | 0.180 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 15 | 0.180 |
Why?
|
| Sex Characteristics | 1 | 2021 | 121 | 0.170 |
Why?
|
| Models, Immunological | 1 | 2019 | 6 | 0.160 |
Why?
|
| Nickel | 1 | 2019 | 30 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2020 | 361 | 0.160 |
Why?
|
| Age Factors | 1 | 2021 | 721 | 0.160 |
Why?
|
| Mice, Knockout | 1 | 2019 | 233 | 0.150 |
Why?
|
| Particle Size | 2 | 2014 | 53 | 0.140 |
Why?
|
| Lipopeptides | 1 | 2016 | 9 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 95 | 0.130 |
Why?
|
| Time Factors | 1 | 2020 | 1329 | 0.130 |
Why?
|
| Female | 3 | 2021 | 13874 | 0.120 |
Why?
|
| Adsorption | 1 | 2014 | 5 | 0.110 |
Why?
|
| Fibronectins | 1 | 2014 | 20 | 0.110 |
Why?
|
| Serum Albumin | 1 | 2014 | 19 | 0.110 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 8 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 83 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 23 | 0.110 |
Why?
|
| Lysosomes | 1 | 2013 | 22 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 62 | 0.110 |
Why?
|
| Synovial Fluid | 1 | 2013 | 96 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 119 | 0.100 |
Why?
|
| Metal-on-Metal Joint Prostheses | 1 | 2013 | 50 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2013 | 131 | 0.100 |
Why?
|
| Adult | 2 | 2020 | 7089 | 0.090 |
Why?
|
| Hip Joint | 1 | 2013 | 377 | 0.080 |
Why?
|
| Hip Prosthesis | 1 | 2013 | 517 | 0.080 |
Why?
|
| Silicones | 1 | 2021 | 9 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2019 | 464 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2019 | 272 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 29 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 42 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 102 | 0.030 |
Why?
|
| Chromium Alloys | 1 | 2014 | 42 | 0.030 |
Why?
|
| Cathepsin B | 1 | 2013 | 5 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 9 | 0.030 |
Why?
|
| Molybdenum | 1 | 2013 | 20 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2013 | 41 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 63 | 0.030 |
Why?
|
| Surface Properties | 1 | 2013 | 128 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2013 | 83 | 0.030 |
Why?
|
| Chromium | 1 | 2013 | 86 | 0.030 |
Why?
|
| Young Adult | 1 | 2014 | 1751 | 0.020 |
Why?
|
| Middle Aged | 1 | 2014 | 8144 | 0.010 |
Why?
|